Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Rat (Rattus) DFNA5 Anticorps:
anti-Human DFNA5 Anticorps:
anti-Mouse (Murine) DFNA5 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
DFNA5 variant is associated with tobacco- and HPV-mediated oral oncogenesis.
DFNA5 methylation shows strong potential as a biomarker for detection of breast cancer. Slightly increased methylation in histologically normal breast tissue surrounding the tumor suggests that it may be a good early detection marker.
In conclusion, our findings firstly revealed that GSDME switches chemotherapy drug-induced caspase-3 dependent apoptosis into pyroptosis in gastric cancer cells.
findings suggest that caspase-3 activation can trigger necrosis by cleaving GSDME and offer new insights into cancer chemotherapy
Genetic variations in the EYA4, GRHL2 and DFNA5 genes and their interactions with occupational noise exposure may play an important role in the incidence of noise-induced hearing loss (NIHL).
Study identified a novel DFNA5 mutation IVS8+1 delG in a Chinese family which led to skipping of exon 8. This is the sixth DFNA5 mutation relates to hearing loss and the second one in DFNA5 intron 8.
We identified a novel c.991-2A>G mutation in DFNA5 which again may lead to exon 8 skipping at the mRNA level.
DFNA5 deletion mutation is associated with autosomal dominant hereditary hearing loss in Japanese families.
DFNA5 protein expression in hepatocellular carcinoma cells was significantly lower than that in normal cells.
DFNA5 is composed of two domains, separated by a hinge region. The first region induces apoptosis when transfected in HEK293T cells, the second region masks and probably regulates this apoptosis inducing capability
A mutation in DFNA5 leads to a type of hearing loss that closely resembles the frequently observed age-related hearing impairment.
A founder effect was demonstrated for the mutation of the DFNA5 gene casusing hearing loss in East Asians.
no significant linkage between age-related hearing impairment (ARHI) and microsatellite markers from the DFNA5 region; there exists no strong association between DFNA5 and ARHI
Here, we report another mutation in DFNA5, a CTT deletion in the polypyrimidine tract of intron 7.
A novel DFNA5 mutation was found in a Dutch family, of which 37 members were examined.
These results suggest that DFNA5 plays a role in the p53-regulated cellular response to genotoxic stress probably by cooperating with p53.
description of a DFNA5 mutation: the insertion of a cytosine at nucleotide position 640 (AF073308.1:_c.640insC, AAC69324.1:_p. Thr215HisfsX8) which does not lead to hearing impairment
GCs induce dfna5 mRNA and its expression appears to be repressed in the basal state. Induction of dfna5 mRNA correlates with GC-dependent apoptosis of CEM cells, though dfna5 expression alone is not sufficient for apoptosis.
DFNA5-associated hearing loss is caused by a very specific gain-of-function mutation.
DFNA5 is a novel tumor suppressor gene in CRC and a valuable molecular marker for human cancer
Because DFNA5-induced secondary necrosis and GSDMD-induced pyroptosis are dependent on CASP3 activation, we propose that they are forms of programmed necrosis.
The identification of the cochlear transcription initiation site (TIS), the core promoter region between relative to the TIS and an enhancer and a silencer element of Dfna5, is described.
Hearing impairment is a heterogeneous condition with over 40 loci described. The protein encoded by this gene is expressed in fetal cochlea, however, its function is not known. Nonsyndromic hearing impairment is associated with a mutation in this gene. Three transcript variants encoding two different isoforms have been found for this gene.
deafness, autosomal dominant 5
, deafness, autosomal dominant 5 homolog
, deafness, autosomal dominant 5 protein
, inversely correlated with estrogen receptor expression 1
, non-syndromic hearing impairment protein 5
, nonsyndromic hearing impairment protein
, hearing impairment protein DFNA5
, non-syndromic hearing impairment protein 5 homolog